Healthcare

Clinical trials involving cognitive conditions need repeatable ways to document changes in patient performance. Cogstate provides computerised tests for functions such as memory, attention and processing speed. Researchers may combine digital testing with clinician-administered instruments depending on the study protocol. This activity contributes to …

Clinical supplies may require ambient, refrigerated, frozen or cryogenic conditions depending on the product. Cryosite offers storage and handling across these conditions, including facilities for liquid nitrogen storage. This activity contributes to the operating profile of Cryosite Limited (ASX:CTE).

The 3base approach changes the complexity of nucleic-acid sequences used for identifying pathogens. EasyScreen assays are designed for multiplex testing, where laboratories examine several potential pathogen targets from a specimen. These attributes make laboratory validation and assay performance central to the company’s commercial proposition.

Healius (ASX:HLS) carries a consensus analyst rating of Hold. Of the 9 analyst recommendations recorded, 1 is Buy or equivalent, 5 are Hold and 3 are Sell or equivalent. The mean price target is A$0.47, with targets ranging from A$0.35 to A$0.73, against a …

Clinuvel (ASX:CUV) carries a consensus analyst rating of Buy. Of the 7 analyst recommendations recorded, 4 are Buy or equivalent, 3 are Hold and 0 are Sell or equivalent. The mean price target is A$18.45, with targets ranging from A$9.52 to A$39.30, against a …

PolyNovo (ASX:PNV) carries a consensus analyst rating of Buy. Of the 7 analyst recommendations recorded, 5 are Buy or equivalent, 2 are Hold and 0 are Sell or equivalent. The mean price target is A$1.25, with targets ranging from A$0.95 to A$1.70, against a …

Integral Diagnostics (ASX:IDX) carries a consensus analyst rating of Buy. Of the 13 analyst recommendations recorded, 11 are Buy or equivalent, 2 are Hold and 0 are Sell or equivalent. The mean price target is A$2.98, with targets ranging from A$2.24 to A$3.70, against …